Skip to main content

Table 2 Modeling diagnostic of the metabolic data derived from plasma samples of various time points after GalN/LPS treatment

From: A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice

PLS model Components Modeling diagnostic
   R2X R2Y Q2Y
4 h 1 0.186 0.288 0.225
  2 0.256 0.412 0.368
  3 0.335 0.556 0.406
5 h 1 0.351 0.742 0.701
  2 0.471 0.876 0.812
  3 0.504 0.915 0.857
6 h 1 0.367 0.781 0.666
  2 0.433 0.896 0.817
  3 0.493 0.941 0.862
  1. Note. 1, 2, or 3 indicates quantities of components contributed to cumulative values. R2X is the fraction of X-variation; R2Y is the fraction of Y-variation; Q2Y is the cumulated cross-validation for R2Y. R2X, R2Y and Q2Y are all ranged from 0 to 1.